Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations
Clinical trial NCT05641298 · WITHDRAWN
Trial details
- NCT number
- NCT05641298
- Sponsor
- Aceragen
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-10
- Primary completion
- 2023-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.